187 related articles for article (PubMed ID: 8741936)
1. Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.
Josselyn SA; Franco VP; Vaccarino FJ
Psychopharmacology (Berl); 1996 Jan; 123(2):131-43. PubMed ID: 8741936
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCKA receptor antagonist.
Josselyn SA; Vaccarino FJ
Pharmacol Biochem Behav; 1996 Nov; 55(3):439-44. PubMed ID: 8951986
[TBL] [Abstract][Full Text] [Related]
3. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM
Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452
[TBL] [Abstract][Full Text] [Related]
4. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.
Mosher JT; Johnson MF; Birkemo LS; Ervin GN
Peptides; 1996; 17(3):483-8. PubMed ID: 8735976
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT
Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145
[TBL] [Abstract][Full Text] [Related]
6. Evidence for CCK(A) receptor involvement in the acquisition of conditioned activity produced by cocaine in rats.
Josselyn SA; De Cristofaro A; Vaccarino FJ
Brain Res; 1997 Jul; 763(1):93-102. PubMed ID: 9272833
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
8. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.
Higgins GA; Nguyen P; Sellers EM
Brain Res; 1992 Feb; 572(1-2):208-15. PubMed ID: 1611514
[TBL] [Abstract][Full Text] [Related]
9. Individual differences in the feeding response to CCKB antagonists: role of the nucleus accumbens.
Sills TL; Vaccarino FJ
Peptides; 1996; 17(4):593-9. PubMed ID: 8804067
[TBL] [Abstract][Full Text] [Related]
10. Examining the role of cholecystokinin in appetitive learning in the infant rat.
Weller A; Tsitolovskya L; Gispan IH; Rabinovitz S
Peptides; 2001 Aug; 22(8):1317-23. PubMed ID: 11457527
[TBL] [Abstract][Full Text] [Related]
11. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
Ebenezer IS; Baldwin BA
Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
[TBL] [Abstract][Full Text] [Related]
12. Devazepide, a CCK(A) antagonist, attenuates the satiating but not the preference conditioning effects of intestinal carbohydrate infusions in rats.
Pérez C; Lucas F; Sclafani A
Pharmacol Biochem Behav; 1998 Feb; 59(2):451-7. PubMed ID: 9476995
[TBL] [Abstract][Full Text] [Related]
13. Interaction of CCKB receptors with amphetamine in responding for conditioned rewards.
Josselyn SA; Vaccarino FJ
Peptides; 1995; 16(5):959-64. PubMed ID: 7479342
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.
Phillips GD; Le Noury J; Wolterink G; Donselaar-Wolterink I; Robbins TW; Everitt BJ
Behav Brain Res; 1993 Jun; 55(2):223-31. PubMed ID: 8357529
[TBL] [Abstract][Full Text] [Related]
15. Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.
Hernando F; Fuentes JA; Ruiz-Gayo M
Br J Pharmacol; 1996 May; 118(2):400-6. PubMed ID: 8735644
[TBL] [Abstract][Full Text] [Related]
16. Effect of the CCKA antagonist devazepide on eating stimulated by raphe injection of 8-OH-DPAT.
Currie PJ; Coscina DV
Neuroreport; 1995 Dec; 7(1):253-6. PubMed ID: 8742464
[TBL] [Abstract][Full Text] [Related]
17. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
Francis J; Dourish CT; Cooper SJ
Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a muscarinic acetylcholine receptor antagonist impairs the acquisition of conditioned reward learning in rats.
Nisanov R; Galaj E; Ranaldi R
Neurosci Lett; 2016 Feb; 614():95-8. PubMed ID: 26768226
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
Brenner LA; Ritter RC
Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
